missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human ANKRD11 (aa 640-733) Control Fragment Recombinant Protein
Click to view available options
Quantity:
100 μL
Unit Size:
100µL
Description
Highest antigen sequence indentity to the following orthologs: Mouse (84%), Rat (84%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-65561 (PA5-65561. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
ANKRD11 is a member of a novel family of ankyrin repeats containing cofactors (ANCOs) that interact with p160 coactivators to inhibit ligand-dependent transactivation. ANKRD11 encodes a large nuclear protein with five ankyrin repeats, and parts of its sequences have been reported as nasopharyngeal carcinoma susceptibility protein and medulloblastoma antigen. This gene also colocalizes and interacts with histone deacetylases.
Specifications
Specifications
| Accession Number | Q6UB99 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 29123 |
| Name | Human ANKRD11 (aa 640-733) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | 2410104C19Rik; 3010027A04Rik; 6330578C09Rik; 9530048I21Rik; AA930108; ANCO1; ANCO-1; ANKRD11; ankyrin repeat domain 11; ankyrin repeat domain-containing protein 11; Ankyrin repeat-containing cofactor 1; fc59e05; fi04c06; Gm176; LOW QUALITY PROTEIN: ankyrin repeat domain-containing protein 11; LZ16; nasopharyngeal carcinoma susceptibility protein; T13; truncated ankyrin repeat domain 11 aberrant transcript 1; truncated ankyrin repeat domain 11 aberrant transcript 2; wu:fc59e05; wu:fi04c06; Yod |
| Common Name | ANKRD11 |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction